Client News
Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting
6th June 2023
Carbios aims to be a leader in growing r-PET market with an ambition to capture 8 to 12% share by 2035 through licensing model
6th June 2023
Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expression
5th June 2023
Element Materials creates a new Lab Solutions division within Life Sciences, providing advanced equipment for laboratories
5th June 2023
Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in France
1st June 2023
Medigene AG: Medigene Announces Pipeline Expansion into Neoantigens with Programs Targeting Multiple KRAS Mutations and HLAs
1st June 2023
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
1st June 2023
Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients
1st June 2023
Carbios will receive grants totaling €54 million from French State via France 2030 and Grand-Est Region[1] to finance construction of world’s first PET biorecycling plant and accelerate R&D activities
31st May 2023
There is no more content to load